To be the trusted partner in UpToDate advanced laboratory diagnostics and research, known for our commitment to precision, efficiency, and continuous innovation, enhancing the quality of patient outcomes, medical research, industries and contributing to advancements in medical science.
Our mission is to provide accurate, timely, and highly specialized laboratory services to support healthcare providers, researchers and pharmaceutical companies in utilizing state-of-the-art technology and adhering to the highest standards of quality and ethical practices for laboratory services.
List Specialized Equipment
Ion Torrent IONS5 Next Generation Sequencer
3500 Genetic Analyzer
Quantstudio 5 Real Time PCR
Versant PCR Real Time PCR
SimpliAmp & Touch Gene Thermal Cyclers
QIA Cube HT / QIA Automated nucleic acids extractors
BD FACSCLyric flow cytometry
BD FACSCanto II flow cytometry
Spectra Optia Apheresis System
Trinocular Olympus Microscope Karyotyping Software
Trinocular Olympus Microscope FISH Software
Fluorescent microscope Olympus BX43
Inverted microscopy
Cold Room
Atellica SCI system & Dimension EXL & Centaur XPT clinical chemistry and immune systems
Tosoh Automated HPLC
Abbot Architect I 1000SR Chemiluminescence analyzers
BN Prospec & BIO FLASH analyzers
Sysmex XN1000 & Atellica Hema haematology analyzers
Sysmex CS-5100 & Sysmex CS-2500 & Sysmex CA660 Coagulation analyzers
unique expertise/technologies
Our unit Home to world-renowned professors in the field, equipped with cutting-edge technologies that drive innovation and set new benchmarks for excellence.
We are unique in the fields of Genomics, Bioinformatics, Karyotyping, FISH, Immunophenotyping, Immunofluorescence, Hematology and Clinical Chemistry
University researchers;Industry partners;Entrepreneurs;Startups;
beneficaiaries access the services
Both Collaboration agreements and Fee-based services
List any past collaborations with industry or any other institution
- Ministry of Health; 100 Million Health Projects
-Clinical Trials with pharmaceutical Companies through Clinical trial center of Faculty of Medicine
-Science and Technology Development Fund
- Higher education funding projects
- Muhammad Ragab Foundati
Key Outcomes
The AUHLs has accomplished several noteworthy milestones, such as:
Obtaining accreditation in accordance with ISO 15198 standards for Chemistry, Hematology, Immunology, and molecular Biology labs.
Modernizing the Alexandria University Hospitals Central Lab with state-of-the-art equipment.
Integrating the Torrent S5 sequencer device into the Cancer Genetics Unit, which was funded and established by the STDF funding project
Upgrading the Immunology Unit through the higher education labs accreditation projects.
Starting the Therapeutic Unit of University Blood Banks to introduce the Clinical Regenerative Medicine applications (PRP, Fibrin Glue, Plasmapheresis, stem cell research .)
Creating The 1st specialized COVID19 lab to aid in community outreach, research, and testing throughout the pandemic.
These accomplishments highlight the lab's dedication to excellence, creativity, and promptness in providing cutting-edge medical services and meeting urgent demands in diagnosis and treatment across multiple specialized areas.
Our clinical laboratory aims to leverage mutual expertise, resources, and networks to UpToDate advance laboratory solutions, drive innovation, and make a global impact.
What are the funding sources to operate the "Unit"?
Self-funding through Fee-based services. Collaborations with pharmaceutical companies for clinical trials and research funding. Academic institutions offering research grants and collaborations. Private foundations focused on healthcare, diagnostics, or medical research. State or local government grants for healthcare initiatives. Industry partnerships and collaborations for research and development funding.
Is the "Unit" charging fees against its services?
Yes;No;
What are the major operational challenges?
Funding gaps;Equipment maintenance;
activities that Unit can contribute to, in the Technology Park
Research and Development;Technology Transfer;Training and Education;Consulting Services;
List planned upgrades/expansions of the "Unit"
Expand the scope of services provided by AUHLs to meet the growing global demands for high quality laboratory services and to stop the outsourcing of Egyptian samples to labs outside Egypt.
Introduce new unique laboratory investigations and techniques do not present in Egypt like:
Establishment of Cell and Gene Therapy Center for manufacturing of cancer cell and gene therapies (CAR-T, CAR-NK, TILs).
Establishment of the 1st Placental Biobank in Egypt associated with the manufacturing of Placental derivatives (Cord blood PRP, Amniotic membrane grafts, Cord blood stem cells, placental extracts)
What additional services can the "Unit" offer?
Whole genome and Exome sequencing
Genomic and chemical Neonatal screening for metabolic disorders.
Manufacturing Biomaterials as Nano fat, BMAC and stromal vascular fraction (SVF).
If needed, what is the support expected from the Technology Park?
Helping in marketing for services provided by the Unit.
Helping in building strong relationships with legislators, funders, and community members.
Helping in funding the future expansions.